Overall, this study demonstrated that ADAM10 functions as a diagnostic, prognostic, and predictive biomarker for lung cancer, indicating its potential as a therapeutic target through modification of ADAM10 levels. The gene discussed is ADAM10; the disease is lung carcinoma.